HALO logo
halo search icon
2269
Wuxi Biologics (Cayman) Inc.

2269 · Wuxi Biologics (Cayman) Inc.

54.10

HKD
-2.60 (-4.586%)
08/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$233.40B

PE

23.80

EV/EBITDA

13.6

DIV Yield

0%

Payout Ratio

0%

MQV Rating

1Very Strong

As at 08/10/2026 12:00:00 AM

Price Chart

Description

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Earnings Momentum
  • HALO Momentum
  • HALO MQV
  • HALO Price Momentum
  • Short Term Trend - Long

Key Fundamentals

EPS 3 yr Growth

15.00%

EBITDA Margin

38.50%

Operating Cashflow

¥6,558m

Free Cash Flow Return

14.00%

ROIC

10.50%

Interest Coverage

58.60

Quick Ratio

3.00

Performance

52 weeks range

Low 28.48 - 58

Trade Value (12mth)

US$39,224,003.00

1 week

5.98%

1 month

15.01%

YTD

74.25%

1 year

43.18%

All time high

148.00

Additional Data

Shares Outstanding (Fully Diluted)

4,181m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Neutral

Halo Model

Mqv

Very Strong

Garp

Neutral

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Neutral

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
20 August 25Flash
26 March 25Flash

Key Stakeholders

NameTitle
Wuxi Biologics Holdings Ltd.Private Company
Zhi Sheng ChenIndividual
Invesco Great Wall Fund Management Co. Ltd.Joint Venture
Wei Chang ZhouIndividual
Xue Jun GuIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
The current share price of Wuxi Biologics (Cayman) Inc. (2269:HKG) is HKDHK$54.10.
2
What is the 52-week high share price for Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
The 52-week high share price for Wuxi Biologics (Cayman) Inc. (2269:HKG) is HKDHK$58.00.
3
What is the 52-week low share price for Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
The 52-week low share price for Wuxi Biologics (Cayman) Inc. (2269:HKG) is HKDHK$28.48.
4
What is the dividend yield for Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
Wuxi Biologics (Cayman) Inc. (2269:HKG) does not pay a dividend.
5
What was Wuxi Biologics (Cayman) Inc. (2269:HKG) last dividend payment?
Halo FAQ
Wuxi Biologics (Cayman) Inc. (2269:HKG) does not pay a dividend.
6
What is the franking level for Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
Wuxi Biologics (Cayman) Inc. (2269:HKG) has a franking level of 0.00%.
7
In which sector is Wuxi Biologics (Cayman) Inc. (2269:HKG) classified?
Halo FAQ
Wuxi Biologics (Cayman) Inc. (2269:HKG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Wuxi Biologics (Cayman) Inc. (2269:HKG)?
Halo FAQ
The current P/E ratio for Wuxi Biologics (Cayman) Inc. (2269:HKG) is 23.80.